Actinium Pharmaceuticals (ATNM) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
ATNM jumps 6.6% to $1.13. Closed at $1.13, +6.60% vs the prior close of $1.06. Day range $1.05–$1.15, opened at $1.09.
ATNM daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — ATNM jumps 6.6% to $1.13
- Closed at $1.13, +6.60% vs the prior close of $1.06. Day range $1.05–$1.15, opened at $1.09.
- Volume was 174.39K shares, 1.1x its 50-day average of 151.68K.
- Price is +3.2% vs its 50-day average ($1.09) and +1.1% vs its 200-day average ($1.12).
- 52-week range $0.74–$1.74; today's close sits at 39% of that range, 35.1% below the 52-week high.
Oct 15, 2026 — ATNM jumps 8.7% to $1.06
- Closed at $1.06, +8.72% vs the prior close of $0.98. Day range $0.95–$1.07, opened at $0.95.
- Volume was 143.20K shares, 0.9x its 50-day average of 155.81K.
- Price is -2.6% vs its 50-day average ($1.09) and -5.3% vs its 200-day average ($1.12).
- 52-week range $0.74–$1.74; today's close sits at 32% of that range, 39.1% below the 52-week high.
- SEC filings that day: 8-K.
Oct 14, 2026 — ATNM dips 2.5% to $0.98, a 1-month low, 3 down days in a row
- Closed at $0.98, -2.50% vs the prior close of $1.00. Day range $0.95–$1.02, opened at $0.99.
- Volume was 84.60K shares, 0.5x its 50-day average of 155.96K — lighter than usual.
- Price is -9.9% vs its 50-day average ($1.08) and -13.0% vs its 200-day average ($1.12).
- 52-week range $0.74–$1.74; today's close sits at 24% of that range, 44.0% below the 52-week high.
- That makes 3 straight losses.
Oct 13, 2026 — ATNM slides 5.7% to $1.00, a 1-month low
- Closed at $1.00, -5.66% vs the prior close of $1.06. Day range $1.00–$1.07, opened at $1.07.
- Volume was 87.90K shares, 0.6x its 50-day average of 158.20K — lighter than usual.
- Price is -7.3% vs its 50-day average ($1.08) and -11.0% vs its 200-day average ($1.12).
- 52-week range $0.74–$1.74; today's close sits at 26% of that range, 42.5% below the 52-week high.
Oct 12, 2026 — ATNM slides 3.6% to $1.06, a 1-month low
- Closed at $1.06, -3.64% vs the prior close of $1.10. Day range $1.03–$1.09, opened at $1.09.
- Volume was 97.60K shares, 0.6x its 50-day average of 156.95K.
- Price is -1.4% vs its 50-day average ($1.07) and -5.9% vs its 200-day average ($1.13).
- 52-week range $0.74–$1.74; today's close sits at 32% of that range, 39.1% below the 52-week high.
Oct 9, 2026 — ATNM rises 1.9% to $1.10
- Closed at $1.10, +1.85% vs the prior close of $1.08. Day range $1.07–$1.12, opened at $1.09.
- Volume was 105.80K shares, 0.7x its 50-day average of 155.36K.
- Price is +2.8% vs its 50-day average ($1.07) and -2.6% vs its 200-day average ($1.13).
- 52-week range $0.74–$1.74; today's close sits at 36% of that range, 36.8% below the 52-week high.
Oct 8, 2026 — ATNM rises 0.9% to $1.08
- Closed at $1.08, +0.93% vs the prior close of $1.07. Day range $1.06–$1.10, opened at $1.09.
- Volume was 104.90K shares, 0.7x its 50-day average of 154.88K.
- Price is +1.4% vs its 50-day average ($1.07) and -4.5% vs its 200-day average ($1.13).
- 52-week range $0.74–$1.74; today's close sits at 34% of that range, 37.9% below the 52-week high.
Oct 7, 2026 — ATNM slides 3.6% to $1.07, a 1-month low
- Closed at $1.07, -3.60% vs the prior close of $1.11. Day range $1.05–$1.12, opened at $1.08.
- Volume was 100.10K shares, 0.6x its 50-day average of 154.33K.
- Price is +0.9% vs its 50-day average ($1.06) and -5.7% vs its 200-day average ($1.13).
- 52-week range $0.74–$1.74; today's close sits at 33% of that range, 38.5% below the 52-week high.
Oct 6, 2026 — ATNM slides 7.5% to $1.11 on 3.0x normal volume
- Closed at $1.11, -7.50% vs the prior close of $1.20. Day range $1.02–$1.22, opened at $1.20.
- Volume was 439.60K shares, 3.0x its 50-day average of 148.01K — unusually heavy trading.
- Price is +5.1% vs its 50-day average ($1.06) and -2.4% vs its 200-day average ($1.14).
- 52-week range $0.74–$1.74; today's close sits at 37% of that range, 36.2% below the 52-week high.
Oct 5, 2026 — ATNM rises 2.6% to $1.20, 3 up days in a row
- Closed at $1.20, +2.56% vs the prior close of $1.17. Day range $1.16–$1.24, opened at $1.16.
- Volume was 115.00K shares, 0.8x its 50-day average of 147.97K.
- Price is +14.2% vs its 50-day average ($1.05) and +5.3% vs its 200-day average ($1.14).
- 52-week range $0.74–$1.74; today's close sits at 46% of that range, 31.0% below the 52-week high.
- That makes 3 straight gains.
Oct 2, 2026 — ATNM rises 1.7% to $1.17
- Closed at $1.17, +1.74% vs the prior close of $1.15. Day range $1.12–$1.19, opened at $1.15.
- Volume was 81.80K shares, 0.5x its 50-day average of 148.94K — lighter than usual.
- Price is +12.0% vs its 50-day average ($1.04) and +2.5% vs its 200-day average ($1.14).
- 52-week range $0.74–$1.74; today's close sits at 43% of that range, 32.8% below the 52-week high.
ATNM latest news & SEC filings
Every SEC filing by or about ATNM in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 16, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- David Matthew T received an award of 250,000 shares on Oct 14, 2026; now holds 250,000
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 16, 2026 · Form 3 — New insider holdings
Initial insider ownership statement (Form 3) — a new director, officer or 10% owner disclosed their holdings
Oct 16, 2026 · Form ARS — Annual report to shareholders
Annual report to shareholders
Oct 16, 2026 · Form DEF 14A — Proxy statement
Proxy statement — agenda for the shareholder meeting (board elections, executive pay, votes)
Oct 15, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Oct 9, 2026 · Form S-8 — Employee share plan registration
Registration of shares for employee stock plans (S-8)
Sep 10, 2026 · Form 3 — New insider holdings
Initial insider ownership statement (Form 3) — a new director, officer or 10% owner disclosed their holdings
Sep 10, 2026 · Form 3 — New insider holdings
Initial insider ownership statement (Form 3) — a new director, officer or 10% owner disclosed their holdings
Sep 4, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 4, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 14, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 3.01 — Stock exchange listing notice or transfer of listing.
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Aug 7, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $35.00M
- Net income: $27.90M (prior year -$6.88M) (swung to profit vs Jun 30, 2025)
- Diluted EPS: $0.89 (prior year -$0.22) (swung to profit vs Jun 30, 2025)
Things to know before you trade ATNM
- Last results release: Aug 3, 2015 (8-K Item 2.02).
- How much it moves: over the last 20 sessions the average daily move was 3.07% (largest 8.7%). That is a volatile stock.
- Liquidity: about 112.78K shares (≈$127.45K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $1.13 vs a range of $0.74–$1.74 (39% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 8-K Oct 15, 2026; 8-K Aug 14, 2026; 10-Q Aug 7, 2026.
- Share count: 31.44M shares outstanding (Aug 6, 2026), +0.8% vs a year earlier.
- Listing: NYSE · industry: Pharmaceutical Preparations.
ATNM market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 1.09 | 1.15 | 1.05 | 1.13 | 174.39K |
| Oct 15, 2026 | 0.95 | 1.07 | 0.95 | 1.06 | 143.20K |
| Oct 14, 2026 | 0.99 | 1.02 | 0.95 | 0.98 | 84.60K |
| Oct 13, 2026 | 1.07 | 1.07 | 1.00 | 1.00 | 87.90K |
| Oct 12, 2026 | 1.09 | 1.09 | 1.03 | 1.06 | 97.60K |
| Oct 9, 2026 | 1.09 | 1.12 | 1.07 | 1.10 | 105.80K |
| Oct 8, 2026 | 1.09 | 1.10 | 1.06 | 1.08 | 104.90K |
| Oct 7, 2026 | 1.08 | 1.12 | 1.05 | 1.07 | 100.10K |
| Oct 6, 2026 | 1.20 | 1.22 | 1.02 | 1.11 | 439.60K |
| Oct 5, 2026 | 1.16 | 1.24 | 1.16 | 1.20 | 115.00K |
| Oct 2, 2026 | 1.15 | 1.19 | 1.12 | 1.17 | 81.80K |
| Oct 1, 2026 | 1.11 | 1.15 | 1.11 | 1.15 | 90.80K |
| Sep 30, 2026 | 1.14 | 1.20 | 1.10 | 1.12 | 95.10K |
| Sep 29, 2026 | 1.17 | 1.17 | 1.14 | 1.14 | 62.00K |
| Sep 28, 2026 | 1.18 | 1.20 | 1.17 | 1.18 | 75.40K |
| Sep 25, 2026 | 1.19 | 1.21 | 1.18 | 1.20 | 28.40K |
| Sep 24, 2026 | 1.19 | 1.25 | 1.18 | 1.19 | 84.80K |
| Sep 23, 2026 | 1.17 | 1.21 | 1.16 | 1.18 | 130.40K |
| Sep 22, 2026 | 1.18 | 1.22 | 1.17 | 1.17 | 54.50K |
| Sep 21, 2026 | 1.24 | 1.24 | 1.17 | 1.20 | 99.40K |
About Actinium Pharmaceuticals
Actinium Pharmaceuticals (ATNM) is listed on the NYSE and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in NEW YORK, NY. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1388320.
ATNM board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| June Sherie Almenoff | Director | Sep 4, 2026 |
| Jeffrey W. Chell | Director | Sep 4, 2026 |
| C. David Nicholson, | Director | Sep 4, 2026 |
| Sandesh Seth | Chief Executive Officer | Sep 4, 2026 |
| Ajit Shetty | Director | Sep 4, 2026 |
| Richard I Steinhart | Director | Sep 4, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Steffen Wilhem Heeger | Chief Medical Officer | Sep 10, 2026 |
| Adeela Kamal | Chief Scientific Officer | Sep 10, 2026 |
| Sandesh Seth | Chief Executive Officer | Sep 4, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
ATNM financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $90.00K | $-33.89M | -1.09 | $-24.58M |
| Dec 31, 2024 | — | $-38.24M | -1.27 | $-33.07M |
| Dec 31, 2023 | $81.00K | $-48.82M | -1.83 | $-47.34M |
| Dec 31, 2022 | $1.03M | $-33.02M | -1.37 | $8.64M |
| Dec 31, 2021 | $1.14M | $-24.77M | -1.20 | $-20.87M |
Latest balance sheet: total assets $40.16M, total liabilities $9.86M, cash $36.47M (as of Jun 30, 2026).
ATNM earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 3, 2015 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on ATNM
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.